A 7-year-old child with acute lymphoblastic leukemia (ALL) is receiving chemotherapy and has developed severe neutropenia with an absolute neutrophil count (ANC) of 200 cells/mm³. The child develops a fever of 101.5°F (38.6°C). What is the most appropriate immediate nursing intervention?

Febrile neutropenia in pediatric oncology patients is a medical emergency requiring immediate antibiotic administration to prevent sepsis. Other options delay critical treatment.

Understanding the Clinical Scenario
The child in this question is experiencing febrile neutropenia (FN), a critical oncologic emergency. With an absolute neutrophil count (ANC) of 200 cells/mm³, the child is severely neutropenic and has lost the primary cellular defense against bacterial and fungal pathogens. In this immunocompromised state, a fever of 101.5°F (38.6°C) is not a routine symptom; it is a medical emergency that signals a potentially life-threatening infection. The absence of neutrophils means the body cannot mount a typical inflammatory response, so a fever may be the only initial sign of a rapidly progressing bloodstream infection (BSI).

Why Immediate Antibiotic Administration is the Priority
The most appropriate immediate nursing intervention is to notify the physician and prepare for emergency antibiotic administration. The rationale is rooted in the time-sensitive nature of FN management. A foundational study on pediatric FN treatment demonstrated that adapting standard operating procedures to reduce the time-to-antibiotic (TTA) is a critical step in improving patient prognosis ^[1]. Any delay in administering empiric broad-spectrum antibiotics directly correlates with increased morbidity and mortality from sepsis. The nurse’s role is to recognize that the physician’s order for antibiotics is a predictable, protocol-driven response, and the nurse must proactively prepare for administration by ensuring IV access, obtaining the correct weight-based medication, and having emergency equipment ready. Waiting for a physician order without simultaneous preparation introduces a clinically significant and dangerous delay.

Analyzing the Incorrect Options
- Option 1 (Administer acetaminophen and monitor): This is dangerous in a neutropenic patient. Administering an antipyretic masks the fever, which is a critical diagnostic clue and a key indicator of the patient’s response to antimicrobial therapy. Routine temperature monitoring is part of care, but it is never the priority intervention over initiating definitive treatment for the suspected infection.
- Option 2 (Obtain blood cultures and wait): Obtaining blood cultures is a necessary step in the diagnostic workup for FN, as it helps identify the causative organism, which is often a Gram-negative or Gram-positive bacteria . However, this action must not delay the administration of antibiotics. The cultures should be drawn urgently, and the antibiotics should be started immediately afterward, without waiting for the physician to review the results or give a separate order if a standing FN protocol exists. The phrase "wait for physician orders before further action" makes this option incorrect because it promotes a passive and delayed response.
- Option 3 (Place in protective isolation and restrict visitors): Protective isolation is an important infection prevention measure for severely neutropenic patients to protect them from external pathogens. However, in the context of an active fever, the immediate threat is an endogenous or already-acquired infection that has now disseminated. Addressing the suspected infection with antibiotics takes absolute priority over environmental controls. The child’s own microbial flora is the most likely source of infection at this moment.

Connecting Clinical Signs to the Underlying Risk
The urgency of this scenario is underscored by the high risk of bloodstream infection in this population. Research indicates that a significant proportion of pediatric FN cases, around 30.2% in one prospective study, are complicated by confirmed bloodstream infections . Furthermore, a fever in a child with leukemia can present a diagnostic dilemma, as it may arise from the infection itself or from a blood product transfusion. A clinical prediction model has been developed to help distinguish a post-transfusion febrile reaction from an early BSI at the bedside, highlighting the diagnostic challenge and the principle that infection must be assumed until proven otherwise . Even dynamic changes in hematologic parameters are being studied to create models that predict short-term clinical deterioration within 7 days in children with ALL, reinforcing that clinical events can evolve rapidly and require a proactive, rather than reactive, management strategy . The nurse’s immediate action of preparing for emergency antibiotics directly confronts the most likely and most lethal threat: an overwhelming bacterial infection in a host with no neutrophil defense.